Non-profit
Providence, RI
USA
Email: rbaier@healthcentricadvisors.org
Papers:
154
Impact of Non-FDA-Approved CLSI Breakpoint Criteria on Laboratory Carbapenem-Resistant Enterobacteriaceae Detection Practices: A State-Wide Assessment